Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2011
08/30/2011CA2378893C In vivo induction for enhanced function of isolated hepatocytes
08/30/2011CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/30/2011CA2331329C Diacylglycerol acyl transferase proteins
08/25/2011WO2011102149A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/25/2011WO2011101602A1 Nanoemulsion for the delivery of at least two agents of interest
08/25/2011WO2011101600A1 Use of a neutralising composition by ingestion to treat or prevent the appearance of aphthas
08/25/2011WO2011101374A1 Compositions comprising amphetamin and lisdexamfetamine
08/25/2011WO2011101340A1 Zeolite-containing preparations containing clinoptilolite and uses thereof
08/25/2011WO2011101113A1 Pharmaceutical comprising myramistin
08/25/2011WO2011100994A1 Pharmaceutical comprising myramistin
08/25/2011WO2011076946A3 Methods and compositions for the treatment of alzheimer
08/25/2011US20110207806 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
08/25/2011US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011US20110207658 High Purity Lipopeptides
08/25/2011US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011US20110206671 Axon regeneration promoter
08/25/2011US20110206664 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
08/25/2011US20110206636 Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
08/25/2011US20110206635 Uses of il-12 in hematopoiesis
08/25/2011US20110206631 Ion binding polymers and uses thereof
08/25/2011US20110206622 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto
08/25/2011US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
08/25/2011US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011CA2789665A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
08/24/2011EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011EP2360185A2 Administration of agents for the treatment of inflammation
08/24/2011EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011EP2360169A2 PSMA antibodies
08/24/2011EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011EP2359852A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
08/24/2011EP2359849A1 Combination therapy
08/24/2011EP2359847A1 Modulation of beta-amyloid levels by beta-secretase bace2
08/24/2011EP2359840A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
08/24/2011EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011EP2359829A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
08/24/2011EP2359826A1 Combination of HMG-COA reductase inhibitors, such as roflumilast, roflumilast-N-oxide with a phosphodiesterase 4 inhibitor, rosuvastatin, for the treatment of inflammatory pulmonary diseases
08/24/2011EP2359688A1 Organ arrest, protection and preservation
08/24/2011EP2358378A2 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
08/24/2011EP1901775B1 Kinin antagonists for treating bladder dysfunction
08/24/2011EP1572128B1 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/24/2011EP1531843B1 Method for treating cervical cancer
08/24/2011EP1505990B1 Methods of treating hepatitis
08/24/2011EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
08/24/2011EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
08/24/2011EP1485353B1 New inhibitors of histone deacetylase
08/24/2011EP1259544B1 Heterologous polypeptide of the tnf family
08/24/2011EP1023067B2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/24/2011EP0754059B2 Methods and compositions useful for inhibition of angiogenesis
08/24/2011CN1775289B Multi vitamin oral disintegrating tablet formulation and its preparing method
08/24/2011CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides
08/24/2011CN102164614A Use of an Ang-(1-7) receptor agonist in acute lung injury
08/24/2011CN102164594A Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
08/24/2011CN102160891A Hcv ns3-ns4a protease inhibition
08/24/2011CN101102776B Antitumor agent
08/23/2011USRE42645 Nutritional or therapeutic compositions and methods to increase bodily glutathione levels
08/23/2011US8003776 Mycobacterial antigens expressed during latency
08/23/2011US8003704 Tryptophan metabolite as aldehyde dehydrogenase inhibitor; side effect reduction
08/23/2011US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
08/23/2011US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
08/23/2011US8003630 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer
08/23/2011US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011US8003315 TAOJIKs as modifiers of the beta-catenin pathway and methods of use
08/23/2011US8003131 Biomaterial derived from vertebrate liver tissue
08/23/2011US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
08/23/2011US8003101 Inflammatory mediator antagonists
08/23/2011US8003094 Combination with a solvent, skin buffer and antioxidant to improve solubility and bioavailability for a variety of dosage forms
08/23/2011CA2729518A1 Multiplication of the efficacy of anti-infectious agents by a composition comprising an extract made from dehydrated and partially sodium-free seawater
08/23/2011CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy
08/23/2011CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors
08/23/2011CA2488789C Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide
08/23/2011CA2486078C Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
08/23/2011CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011CA2456076C Integrin inhibitors for the treatment of eye diseases
08/23/2011CA2442159C Treatment using neublastin polypeptides
08/23/2011CA2403994C Nasal administration of agents for the treatment of gastroparesis
08/23/2011CA2348926C Methods and compositions for the prevention of tolerance to medications
08/23/2011CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
08/18/2011WO2011100319A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors
08/18/2011WO2011100285A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
08/18/2011WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
08/18/2011WO2011099031A1 Active antioxidants for all age group
08/18/2011WO2011098698A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures
08/18/2011WO2011098456A1 Safinamide in the treatment of dyskinesia
08/18/2011WO2011079249A3 Vitamin d glycosides and sulfates for treating diseases
08/18/2011US20110201677 Promoters exhibiting endothelial cell specificity and methods of using same
08/18/2011US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
08/18/2011US20110201029 Il-13 receptor antibodies
08/18/2011US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders
08/18/2011US20110200553 Compounds and methods for the treatment or prevention of flavivirus infections
08/18/2011CA2789229A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
08/18/2011CA2783303A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures
08/17/2011EP2357582A1 Methods and devices for identifying patterns in biological systems
08/17/2011EP2357478A2 Diagnosis of disease
08/17/2011EP2357474A1 Lurasidone for use in the treatment of memory or learning dysfunction by schizophrenia
08/17/2011EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011EP2357003A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
08/17/2011EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof
08/17/2011EP2356982A2 Antimicrobial compositions and methods